From Stem Cells to Dopamine Neurons: Developmental Biology Meets Neurodegeneration

Author(s): Jignesh Tailor, Thomas Andreska, Raja Kittappa

Journal Name: CNS & Neurological Disorders - Drug Targets
(Formerly Current Drug Targets - CNS & Neurological Disorders)

Volume 11 , Issue 7 , 2012

Become EABM
Become Reviewer


Neurodegenerative disease affects tens of millions of people, worldwide, and comes at a cost to the public of billions of dollars. Stem cell therapy, in recent years, has generated a lot of enthusiasm as a novel treatment for neurodegenerative disease. In particular, Parkinson’s disease has been identified as the ideal neurodegenerative disease to be treated using stem cells. Despite years of setbacks, recent experimental results have renewed optimism in the validity of stem cell therapy for the treatment of Parkinson’s disease. In this review, we discuss advances in our understanding of the embryonic development of the dopamine system and the importance of these discoveries in the continued efforts towards stem cell therapy for Parkinson’s disease.

Keywords: Dopamine neuron, embryonic stem cells, neural development, neurodegeneration, Parkinson’s disease, stem cell therapy, dopamine system, hemiparkinsonian, motoneurons, oligodendrocytes

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 09 December, 2012
Page: [893 - 896]
Pages: 4
DOI: 10.2174/1871527311201070893
Price: $65

Article Metrics

PDF: 22